MingCeler babban masanin kimiyya

Dokta Guangming Wu, PhD

Dokta Guangming Wu, farfesa na dakin gwaje-gwaje na Guangzhou Bio-land, ya yi aiki a matsayin abokin bincike ko kuma digiri na biyu a Cibiyar Dabbobi ta New England Medical Animal, Jami'ar Brown, Jami'ar Missouri-Columbia, Makarantar Magunguna ta Jami'ar Temple, da sauran mashahuran cibiyoyin bincike na duniya. .A cikin 2004, ya shiga Cibiyar Max Planck don Ilimin Halittu (MPI) a Jamus, inda ya yi aiki tare da Farfesa Hans R. Schöler (Mamba na Kwalejin Kimiyya ta Jamus) game da haɓaka embryos na linzamin kwamfuta da kuma tsarin kwayoyin halitta.

Dokta Wu ya shafe fiye da shekaru 30 yana aiki kan tsarin kwayoyin halittar dan Adam, naman alade, naman dabbobi, da naman rani, da ci gaban mahaifa, da samar da karfin jiki da yawa fiye da shekaru 30, kuma ya kware sosai kan al'adun mahaifa daban-daban da kuma kananan yara. dabarun magudi.Shi ne na farko kuma a halin yanzu kawai masanin kimiyyar da ya kara yawan haihuwar berayen da aka samu daga fasahar diyya ta tetraploid daga kashi 1-5% zuwa 30-60% ta hanyar ingantawa, samun ci gaban masana'antar fasahar.Ya haɗu da takaddun SCI 79 tare da tasirin tasirin tasirin sama da 670 da sama da 7150 kuma ya buga a cikin manyan mujallu na duniya kamar Nature, Cell stem cell, da sauransu.

Domin gagarumin gudunmawar da ya bayar wajen yin magudin haihuwa, sunan Dr. Wu yana baje kolin dindindin a gidan tarihi na Deutsches na Munich, wanda shi ne babban gidan kayan tarihi na kimiyya da fasaha a duniya.

A watan Agustan shekarar 2019, an gabatar da Dr. Wu zuwa kasar Sin a matsayin cikakken mai bincike, shi da tawagarsa sun yi nasarar gina wani samfurin linzamin kwamfuta na ACE2 a cikin kwanaki 35, inda suka kafa "tushen" gwaji don binciken cutar ta COVID-19. duban magunguna, da haɓakar rigakafi.Sakamakon nasarorin da ya samu a fannin kimiyya da fasaha, Dr. Wu ya sami lambar yabo ta "Mai ci gaba a yaki da COVID-19 a lardin Guangdong" a shekarar 2020.

Nasarar haɓakawa da aikace-aikacen fasahar haɓaka fasahar Tetraploid na gaba mai zuwa (TurboMice™ fasaha) a cikin ƙirar linzamin kwamfuta yayin yaƙin COVID-19, yana ƙarfafa Dr. Wu don yin ƙoƙari don haɓaka ƙimar biopharmaceuticals.Sabili da haka, ya kafa Guangzhou MingCeler Biotech Co., Ltd a matsayin babban masanin kimiyya, yana mai da hankali kan sauya fasahar TurboMice ™ daga dakin gwaje-gwaje zuwa aikace-aikacen masana'antu don samar da samfuran beraye masu tsayi da sabis ga jami'o'in duniya, cibiyoyin bincike, asibitoci, da kamfanonin harhada magunguna da ke da hannu a binciken lafiyar rayuwa.